GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Celldex Therapeutics, Inc. (CLDX) [hlAlert]

Celldex Therapeutics, Inc. (Celldex) is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and
other difficult-to-treat diseases. The Company?s immunotherapy platform includes a portfolio of monoclonal antibodies, antibody-targeted vaccines, antibody-drug conjugates and immunomodulators to create disease-specific drug candidates. Its collaborations include the commercialization of an oral human rotavirus vaccine and the development of oncology and infectious disease vaccines. On October 1, 2009, Celldex acquired CuraGen Corporation.
.
( Total: 10 Current Stock Recommendations )
Celldex Therapeutics, Inc.   (10)
Hold Buy 90%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Filter by Gains:   
  
Rating:
Buy CLDX
up 285.45 %

Rating:
Buy CLDX
up 285.45 %

Rating:
Buy CLDX
up 197.44 %

Rating:
Buy CLDX
down 16.84 %
Celldex Therapeutics, Inc. (CLDX) rated Buy by Guggenheim
Wednesday,  Jul 3, 2013  8:25 AM ET

Rating:
Buy CLDX
up 197.44 %

Rating:
Buy CLDX
up 35.75 %

Rating:
Buy CLDX
up 285.45 %

Rating:
Buy CLDX
up 197.44 %

Rating:
Buy CLDX
up 285.45 %

Rating:
Buy CLDX
up 197.44 %

Rating:
Buy CLDX
up 197.44 %

Rating:
Buy CLDX
up 188.91 %

Rating:
Buy CLDX
up 285.45 %

Rating:
Buy CLDX
up 172.25 %

Your Recent Stocks
SymbolLastChange
CLDX 3.76 down  -75.11 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy